Ledger.Open graph →
SEC Form D · filed December 12, 2012

Morria Biopharmaceuticals PLC

Offering
$1.5M
Sold
$1.5M
Exemption
—
Industry
Biotechnology
Location
LONDON, United Kingdom
Type
—

People & firms on this filing (16)

Mark Cohen · NEW YORK, NYDirectorAmos Eiran · HERZELIYA, L3DirectorAlan Harris · NEW YORK, NYExecYuval Cohen · LONDON, United KingdomExec · DirectorPiney Point Capital GP LLC · Milwaukee, WIDirectorDov Elefant · LONDON, United KingdomExecSaul Yedgar · JERUSALEM, L3Exec · DirectorGilead Raday · KEFAR-URIA, L3DirectorNicola (Nick) Sanna · Spokane, WADirectorUri Foox · New York, NYExec · DirectorEliot Buchanan · Boston, MAExecKerry Hatch · Boston, MAExec · DirectorDaniel Choi · Boston, MADirectorMichail Medvinsky · Boston, MADirectorDavid L. Potter · Tampa, FLDirectorRobert Dobbs · Tampa, FLExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗